IL15 and neoplasm: The subsequent generation of primary CAR-NK cells directed against CD44v6, incorporating an IL-15 superagonist and checkpoint inhibitor molecules, exhibited effective anti-tumour activity against 3D spheroid models and resistance to the TME [90].